Associations between expression of indoleamine 2, 3-dioxygenase enzyme and inflammatory cytokines in patients with first-episode drug-naive Schizophrenia

The indoleamine 2,3-dioxygenase (IDO) enzyme is the first rate-limiting enzyme of the tryptophan degradation pathway in which dysfunction of neuroactive metabolites has been implicated in the pathophysiology of schizophrenia. Inflammatory molecules such as pro-inflammatory cytokines could enhance th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yan, Shi, Han, Yang, Ge, Yang, Yongfeng, Li, Wenqiang, Song, Meng, Shao, Minglong, Su, Xi, Lv, Luxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606005/
https://www.ncbi.nlm.nih.gov/pubmed/34802039
http://dx.doi.org/10.1038/s41398-021-01688-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606005/
https://www.ncbi.nlm.nih.gov/pubmed/34802039
http://dx.doi.org/10.1038/s41398-021-01688-x

Ejemplares similares